Cleared Traditional

K902628 - INTERFLO MEDICAL MODEL INTERFLO/1 CARDIAC OUTPUT

K902628 is an FDA 510(k) clearance for INTERFLO MEDICAL MODEL INTERFLO/1 CARDI..., manufactured by Biometric Research Institute, Inc.. The device is a Class 2 Cardiovascular device with product code DXG cleared through the Traditional 510(k) pathway after a 257-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1991
Decision
257d
Days
Class 2
Risk

K902628 is an FDA 510(k) clearance for the INTERFLO MEDICAL MODEL INTERFLO/1 CARDIAC OUTPUT. Classified as Computer, Diagnostic, Pre-programmed, Single-function (product code DXG), Class II - Special Controls.

Submitted by Biometric Research Institute, Inc. (Arlington, US). The FDA issued a Cleared decision on February 25, 1991 after a review of 257 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1435 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K902628

510(k) Number K902628 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 13, 1990
Decision Date February 25, 1991
Days to Decision 257 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
132d slower than avg
Panel avg: 125d · This submission: 257d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXG Device Classification - Class 2, Special Controls

Product Code DXG Computer, Diagnostic, Pre-programmed, Single-function
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1435
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXG Computer, Diagnostic, Pre-programmed, Single-function

All 176
Devices cleared under the same product code (DXG) and FDA review panel - the closest regulatory comparables to K902628.
CONTINUOUS CARDIAC OUTPUT SYSTEM
K932414 · Abbott Laboratories · Nov 1994
IQ SYSTEM
K922218 · Renaissance Technology, Inc. · Dec 1992
MIDAS SYSTEM(TM) 5100 PHYSIOLOG MONIT/RECORD SYST
K913358 · Ppg Industries, Inc. · Dec 1991
CARDIAC OUTPUT COMPUTER, MODEL COM-3
K896930 · Baxter Healthcare Corp · Jul 1990
SORBA MODEL CIC-1000 W/NEW ELECTRODES
K901926 · Sorba Medical Systems, Inc. · Jun 1990
SORBA MODEL CIC-1000, COMP. IMPEDANCE CARDIOGRAPH
K895017 · Sorba Medical Systems, Inc. · Mar 1990